Duan S B, Wei S S, Wang H M, Ding S H, Chen Y Z, Tian J J, Wang Y J, Chen W, Chen J, Meng Q L
Suzhou Institute of Biomedical Engineering and Technology, Suzhou, 215163 China.
Jihua Laboratory, Foshan, 315200 China.
Mol Biol (Mosk). 2021 Nov-Dec;55(6):982-986. doi: 10.31857/S0026898421060057.
When expressing streptavidin recombinant polypeptide on magnetosomes (called bacterial magnetic nanoparticles, or BMPs), the presence of endogenous bacterial biotin might be detrimental. In the study, the streptavidin monomer fragment (S1-116) was fused with the intein N-terminal (termed precursor S1-116-IN), and S1-116-IN was expressed in E. coli (BL21). Meanwhile, the SA117-160 fragment was fused with the C-terminal intein, and then this chimeric polypeptide was expressed on magnetosomes by fusion with magnetosome membrance protein MamF. In the in vitro protein splicing system, the purified engineered magnetosomes (BMP-SA117-160-IC) and the S1-116-IN precursor were mixed. Intein-mediated trans-splicing reaction was induced to produce the functional magnetic beads BMP-SA. Our results indicate that intein-mediated protein trans-splicing may lead to efficient synthesis of the recombinant streptavidin on the magnetosomes, showing its promising potential to produce other functional magnetic nanoparticles.